Genetic Medicine Co. Raises $83.5M For Drug Development
By Matthew Guarnaccia ( August 1, 2017, 3:35 PM EDT) -- A company specializing in gene editing and gene therapy treatments said Tuesday that it raised $83.5 million from private investors to fund the development of new medicines and technologies designed to treat genetic diseases....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.